CTOs on the Move

Alkermes

www.alkermes.com

 
Alkermes plc is a fully integrated, global biopharmaceutical company developing innovative medicines for the treatment of central nervous system (CNS) diseases. The company has a diversified commercial product portfolio and a substantial clinical pipeline of product candidates for chronic diseases that include schizophrenia, depression, addiction and multiple sclerosis. Headquartered in Dublin, Ireland, Alkermes plc has an R&D center in Waltham, Massachusetts; a research and manufacturing facility in Athlone, Ireland; and a manufacturing facility in Wilmington, Ohio.
  • Number of Employees: 1K-5K
  • Annual Revenue: $250-500 Million
  • www.alkermes.com
  • 852 Winter Street
    Waltham, MA USA 02451
  • Phone: +353 1 772 8000

Executives

Name Title Contact Details
Jonathan Brooks
 Senior Director, Global Security Profile
John Lamoureux
 Senior Director of Information Technology Profile
Mike Legato
 Associate Director of Information Technology Applications Profile

Similar Companies

Rocky Mountain CARES

Rocky Mountain CARES – HIV / AIDS Advocacy Group – Denver, Colorado

Sequoia Pharmaceuticals

Sequoia Pharmaceuticals is a Gaithersburg, MD-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

RxElite (Main)

RxElite (Main) is a Meridian, ID-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

CapsoVision

Please select your location. United States International

Rafael Holdings

Rafael Holdings is focused on the development of novel cancer therapies. The company is a significant investor in two clinical stage oncology companies, Rafael Pharmaceuticals, Inc., and LipoMedix Pharmaceuticals Ltd. Through its wholly owned Barer Institute subsidiary, the company is developing a pipeline of compounds focused on the regulation of cancer metabolism.